Stachowska B, Seńczuk W
Int J Clin Pharmacol Ther Toxicol. 1987 Feb;25(2):81-5.
The kinetics of sulfadiazine and trimethoprim excretion was determined. The examinations were performed on 10 healthy people. The compounds were given orally once, in the form of pure substances, applying three different doses: 80, 240 and 720 mg of sulfadiazine and 20, 60 and 180 mg of trimethoprim. In order to estimate the contents of sulfadiazine in urine, Bratton-Marshall's method was applied while the colorimetric method according to Vachek and Kakac was used in estimating the contents of trimethoprim. This method was adapted by Klimowicz to determine trimethoprim in blood and it was modified in our laboratory. It was stated that about 44 per cent of the administered dose of sulfadiazine and about 56 per cent of trimethoprim were excreted with urine in the form of unchanged compounds. The excretion processes of both compounds can be described in the way accepted for one-compartment kinetic models. The value of the half-life of sulfadiazine excretion is 8.4 hours while that of trimethoprim is 6 hours. The constant of loss is 0.083 for sulfadiazine and 0.118 for trimethoprim. The given formulae allow to calculate the rate of excretion of sulfadiazine and trimethoprim with urine at any time after being administered. The tests proposed to calculate the accepted drug doses, which are based on measuring the excretion rate of the unchanged substances with urine, so that they may be applied in controlled therapy and in poison therapy.
测定了磺胺嘧啶和甲氧苄啶的排泄动力学。对10名健康人进行了检测。以纯物质形式口服给予这些化合物,应用三种不同剂量:80、240和720毫克磺胺嘧啶以及20、60和180毫克甲氧苄啶。为了估算尿液中磺胺嘧啶的含量,采用了布拉顿 - 马歇尔法,而在估算甲氧苄啶含量时使用了根据瓦切克和卡卡克的比色法。这种方法由克利莫维茨改编用于测定血液中的甲氧苄啶,并在我们实验室进行了改进。结果表明,给予剂量中约44%的磺胺嘧啶和约56%的甲氧苄啶以未变化的化合物形式随尿液排出。这两种化合物的排泄过程可以用单室动力学模型所接受的方式来描述。磺胺嘧啶排泄的半衰期值为8.4小时,而甲氧苄啶的半衰期值为6小时。磺胺嘧啶的损失常数为0.083,甲氧苄啶的损失常数为0.118。给定的公式可以计算出给药后任何时间磺胺嘧啶和甲氧苄啶随尿液的排泄速率。所提出的测试用于计算公认的药物剂量,这些剂量基于测量未变化物质随尿液的排泄速率,以便可应用于控制治疗和中毒治疗。